FirmaIQ
Org.nr 979 455 518 2009 → 2010 Year-over-year analysis

ACD PHARMACEUTICALS AS: årsregnskap 2010 vs 2009

Grew 31% on revenue

approved 2011-06-27; registry 2011-08-29; journal 2011 647341

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2010 with 2009 for ACD PHARMACEUTICALS AS. Revenue 11.87m NOK → 15.58m NOK (+31.2%). Equity 839.0k NOK → 92.9k NOK.

On the constructive side: revenue rose. Pressures included: equity eroded.

Also worth watching: thin equity buffer; payroll increased; cogs moved. All figures are taken from the published annual accounts for ACD PHARMACEUTICALS AS.

At a glance

Scorecard

Revenue
11.87m NOK 15.58m NOK
+31.2%
Equity
839.0k NOK 92.9k NOK
-88.9%
Total assets
8.38m NOK 12.75m NOK
+52.2%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 11.87m NOK to 15.58m NOK (+31.2% YoY). Calculated

What deteriorated

  • ↓

    Equity eroded

    Book equity 839.0k NOK → 92.9k NOK (equity ratio 10.0% → 0.7%). Calculated

Things to notice

  • ·

    Thin equity buffer

    Equity ratio is 0.7% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation

  • ·

    Payroll increased

    Salary cost 909.7k NOK → 984.0k NOK (8% → 6% of revenue). Calculated

  • ·

    COGS moved

    COGS / varekostnad 6.15m NOK → 8.93m NOK (+45.3% YoY). Calculated